Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-009529
Filing Date
2020-04-20
Accepted
2020-04-20 06:01:21
Documents
6
Period of Report
2020-04-20

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea120830-6k_immuronlimited.htm 6-K 20893
2 IMMURON GLOBAL SALES UP 60% ea120830ex99-1_immuron.htm EX-99.1 26181
3 GRAPHIC image_001.jpg GRAPHIC 1395
4 GRAPHIC ex99-1_001.jpg GRAPHIC 5434
5 GRAPHIC ex99-1_002.jpg GRAPHIC 7112
6 GRAPHIC ex99-1_003.jpg GRAPHIC 3343
  Complete submission text file 0001213900-20-009529.txt   72458
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 20801143
SIC: 2834 Pharmaceutical Preparations